Drug-Mimicking Nanofibrous Peptide Hydrogel for Inhibition of Inducible Nitric Oxide Synthase

• Published in: ACS biomaterials science & engineering Vol. 5; no. 12; pp. 6755 - 6765
• Main Authors: Leach, David G, Newton, Jared M, Florez, Marcus A, Lopez-Silva, Tania L, Jones, Adrianna A, Young, Simon, Sikora, Andrew G, Hartgerink, Jeffrey D
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 09.12.2019
• Subjects: iNOS inhibition; self-assembly; peptide; hydrogel
• ISSN: 2373-9878; 2373-9878
• DOI: 10.1021/acsbiomaterials.9b01447

In this work, we develop a drug-mimicking nanofibrous peptide hydrogel that shows long-term bioactivity comparable to a small-molecule inhibitor of inducible nitric oxide synthase (iNOS). The iNOS inhibitor, N 6-(1-iminoethyl)-l-lysine (l-NIL), is a positively charged amino acid whose structure could be readily integrated into the framework of a positively charged multidomain peptide (MDP) through the modification of lysine side chains. This new l-NIL-MDP maintains the self-assembling properties of the base peptide, forming β-sheet nanofibers, which entangle into a thixotropic hydrogel. The l-NIL-MDP hydrogel supports cell growth in vitro and allows syringe-directed delivery that persists in a targeted location in vivo for several weeks. Multiple characterization assays demonstrate the bioactivity of the l-NIL-MDP hydrogel to be comparable to the l-NIL small molecule. This includes iNOS inhibition of macrophages in vitro, reduced nitrotyrosine immunostaining in murine subcutaneous histology, and reduced serum levels of vascular endothelial growth factor in vivo. This study expands the toolbox of available peptide hydrogel scaffold designs that can modify biological activity without the need for any additional small-molecule drugs, proteins, or cells.